AbCellera Biologics Inc vs Alliant Energy Corporation — how do they compare? AbCellera Biologics Inc trades at $9 (market cap $2.99B), while Alliant Energy Corporation trades at $68.56 (market cap $17.78B). The key difference: Alliant Energy Corporation is far larger — about 5.9× AbCellera Biologics Inc's market cap, and Alliant Energy Corporation pays a 3.12% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | LNT | |
|---|---|---|
Market Cap | $2.99B | $17.78B |
Sector | Health | Utilities |
52-Week High | $9.76 | $78.03 |
52-Week Low | $2.78 | $63.62 |
Enterprise Value | $2.58B | $29.88B |
Dividend Yield | — | 3.12% |
Trailing returns across standard periods
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →Alliant Energy is the parent of two regulated utilities, Interstate Power and Light and Wisconsin Power and Light, serving nearly 1 million electricity and natural gas customers and approximately 420,000 natural gas-only customers. Both subsidiaries engage in the generation and distribution of electricity and the distribution and transportation of natural gas. Alliant also owns a 16% interest in American Transmission Co.
Read more on LNT →